BACKGROUND: African Americans and patients with chronic kidney disease (CKD) are at high risk for clinical heart failure (HF). In this study, we aimed to determine the association of markers of kidney disease with subclinical HF (by echocardiogram) and risk of clinical HF among a large, well-characterized community-based cohort of African American patients. We also examined whether the association of markers of kidney disease with HF was attenuated with adjustment for echocardiographic measures. METHODS: We studied participants in the Jackson Heart Study, a large community-based cohort of African Americans. Estimated glomerular filtration rate (eGFR) and urine albumin:creatinine ratio (ACR) were measured at baseline. We tested the association of eGFR and urine ACR with left ventricular mass (LVM), left ventricular ejection fraction (LVEF) and physician-adjudicated incident HF. RESULTS: Among the 3332 participants in the study, 166 (5%) had eGFR <60 mL/min/1.73 m2 and 405 (12%) had urine ACR ≥30 mg/g. In models adjusted for demographics, comorbidity and the alternative measure of kidney disease, lower eGFR and higher urine ACR were associated with higher LVM {β-coefficient 1.54 [95% confidence interval (CI) 0.78-2.31] per 10 mL/min/1.73 m2 decrease in eGFR and 2.87 (95% CI 1.85-3.88) per doubling of urine ACR}. There was no association of eGFR and urine ACR with LVEF [β-coefficient -0.12 (95% CI -0.28-0.04) and -0.11 (95% CI -0.35-0.12), respectively]. There was no association of eGFR with the risk of incident HF [HR 1.02 (95% CI 0.91-1.14) per 10 mL/min/1.73 m2 decrease], while there was a significant association of urine ACR [HR 2.22 (95% CI 1.29-3.84) per doubling of urine ACR]. This association was only modestly attenuated with adjustment for LVM [HR 1.95 (95% CI 1.09-3.49)]. CONCLUSIONS: Among a community-based cohort of African Americans, lower eGFR and higher ACR were associated with higher LVM. Furthermore, higher urine ACR was associated with incident HF, which was not entirely explained by the presence of left ventricular disease.
BACKGROUND: African Americans and patients with chronic kidney disease (CKD) are at high risk for clinical heart failure (HF). In this study, we aimed to determine the association of markers of kidney disease with subclinical HF (by echocardiogram) and risk of clinical HF among a large, well-characterized community-based cohort of African American patients. We also examined whether the association of markers of kidney disease with HF was attenuated with adjustment for echocardiographic measures. METHODS: We studied participants in the Jackson Heart Study, a large community-based cohort of African Americans. Estimated glomerular filtration rate (eGFR) and urine albumin:creatinine ratio (ACR) were measured at baseline. We tested the association of eGFR and urine ACR with left ventricular mass (LVM), left ventricular ejection fraction (LVEF) and physician-adjudicated incident HF. RESULTS: Among the 3332 participants in the study, 166 (5%) had eGFR <60 mL/min/1.73 m2 and 405 (12%) had urine ACR ≥30 mg/g. In models adjusted for demographics, comorbidity and the alternative measure of kidney disease, lower eGFR and higher urine ACR were associated with higher LVM {β-coefficient 1.54 [95% confidence interval (CI) 0.78-2.31] per 10 mL/min/1.73 m2 decrease in eGFR and 2.87 (95% CI 1.85-3.88) per doubling of urine ACR}. There was no association of eGFR and urine ACR with LVEF [β-coefficient -0.12 (95% CI -0.28-0.04) and -0.11 (95% CI -0.35-0.12), respectively]. There was no association of eGFR with the risk of incident HF [HR 1.02 (95% CI 0.91-1.14) per 10 mL/min/1.73 m2 decrease], while there was a significant association of urine ACR [HR 2.22 (95% CI 1.29-3.84) per doubling of urine ACR]. This association was only modestly attenuated with adjustment for LVM [HR 1.95 (95% CI 1.09-3.49)]. CONCLUSIONS: Among a community-based cohort of African Americans, lower eGFR and higher ACR were associated with higher LVM. Furthermore, higher urine ACR was associated with incident HF, which was not entirely explained by the presence of left ventricular disease.
Authors: A Levin; C R Thompson; J Ethier; E J Carlisle; S Tobe; D Mendelssohn; E Burgess; K Jindal; B Barrett; J Singer; O Djurdjev Journal: Am J Kidney Dis Date: 1999-07 Impact factor: 8.860
Authors: Myra A Carpenter; Richard Crow; Michael Steffes; William Rock; Jeffrey Heilbraun; Gregory Evans; Thomas Skelton; Robert Jensen; Daniel Sarpong Journal: Am J Med Sci Date: 2004-09 Impact factor: 2.378
Authors: Francisco Javier Carrasco-Sánchez; Luis Galisteo-Almeda; Inmaculada Páez-Rubio; Francisco Javier Martínez-Marcos; Crescencio Camacho-Vázquez; Carlos Ruiz-Frutos; Emilio Pujol-De La Llave Journal: J Card Fail Date: 2011-01 Impact factor: 5.712
Authors: Sonja R Fuqua; Sharon B Wyatt; Michael E Andrew; Daniel F Sarpong; Frances R Henderson; Margie F Cunningham; Herman A Taylor Journal: Ethn Dis Date: 2005 Impact factor: 1.847
Authors: Kirsten Bibbins-Domingo; Glenn M Chertow; Linda F Fried; Michelle C Odden; Anne B Newman; Stephen B Kritchevsky; Tamara B Harris; Suzanne Satterfield; Steven R Cummings; Michael G Shlipak Journal: Arch Intern Med Date: 2006-07-10
Authors: W S Post; R S Blumenthal; J L Weiss; D M Levine; D R Thiemann; G Gerstenblith; M N Hill Journal: Am J Hypertens Date: 2000-11 Impact factor: 2.689
Authors: Stephen F Derose; Mark P Rutkowski; Peter W Crooks; Jiaxiao M Shi; Jean Q Wang; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Nathan W Levin; Steven J Jacobsen Journal: Am J Kidney Dis Date: 2013-03-15 Impact factor: 8.860
Authors: Paolo Verdecchia; Peter Sleight; Giuseppe Mancia; Robert Fagard; Bruno Trimarco; Roland E Schmieder; Jae-Hyung Kim; Garry Jennings; Petr Jansky; Jyh-Hong Chen; Lisheng Liu; Peggy Gao; Jeffrey Probstfield; Koon Teo; Salim Yusuf Journal: Circulation Date: 2009-09-21 Impact factor: 29.690
Authors: Hans L Hillege; Dorothea Nitsch; Marc A Pfeffer; Karl Swedberg; John J V McMurray; Salim Yusuf; Christopher B Granger; Eric L Michelson; Jan Ostergren; Jan Hein Cornel; Dick de Zeeuw; Stuart Pocock; Dirk J van Veldhuisen Journal: Circulation Date: 2006-02-07 Impact factor: 29.690
Authors: Senthil Selvaraj; Sanjiv J Shah; Mark J Ommerborn; Cheryl R Clark; Michael E Hall; Robert J Mentz; Saadia Qazi; Jeremy M Robbins; Thomas N Skelton; Jiaying Chen; J Michael Gaziano; Luc Djoussé Journal: Circ Heart Fail Date: 2017-06 Impact factor: 8.790
Authors: Luke N Bailey; Emily B Levitan; Suzanne E Judd; Madeline R Sterling; Parag Goyal; Mary Cushman; Monika M Safford; Orlando M Gutiérrez Journal: JACC Heart Fail Date: 2019-05 Impact factor: 12.035
Authors: Nisha Bansal; Leila R Zelnick; Alvaro Alonso; Emelia J Benjamin; Ian H de Boer; Rajat Deo; Ronit Katz; Bryan Kestenbaum; Jehu Mathew; Cassianne Robinson-Cohen; Mark J Sarnak; Michael G Shlipak; Nona Sotoodehnia; Bessie Young; Susan R Heckbert Journal: Clin J Am Soc Nephrol Date: 2017-08-10 Impact factor: 8.237
Authors: Jordana B Cohen; Wei Yang; Liang Li; Xiaoming Zhang; Zihe Zheng; Paula Orlandi; Nisha Bansal; Rajat Deo; James P Lash; Mahboob Rahman; Jiang He; Tariq Shafi; Jing Chen; Debbie L Cohen; Kunihiro Matsushita; Michael G Shlipak; Myles Wolf; Alan S Go; Harold I Feldman Journal: Am J Kidney Dis Date: 2021-05-28 Impact factor: 8.860